Presenilins: Multifunctional proteins involved in Alzheimer's disease pathology

被引:29
作者
Checler, F [1 ]
机构
[1] Inst Pharmacol Mol & Cellulaire, UPR 411 CNRS, F-06560 Valbonne, France
关键词
A beta peptide; Alzheimer's disease; apoptosis; beta APP processing; caspases; development; embryogenesis; maturation; mutations; presenilins;
D O I
10.1080/152165499307396
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Early-onset aggressive forms of Alzheimer's disease (AD) are of genetic nature and have been linked to inherited mutations located on chromosomes 21, 14, and 1. The gene products of chromosomes 14 and 1, which are responsible for most of these familial forms of the disease (FAD), have been recently identified and referred to as presenilin 1 and 2 (PS1, PS2), respectively. Several lines of evidence derived from neuropathological, cell biology, and transgenesis approaches indicate that PS could interfere with the processing of the beta-amyloid precursor protein (beta APP). Thus, PAD-linked mutations in PS exacerbate the production of A beta 42, the readily aggregable A beta species corresponding to one of the main constituents of the senile plaques that invade the cortical areas of affected brains. Recent studies indicate that PS functions could be intimately related with the susceptibility of PS to further processing by caspase-like enzymes and other unknown proteolytic activities. Here I briefly report on the post-translational events undergone by PS and examine recent advances concerning their possible roles in development, cell signaling, and apoptosis, Possible alterations brought by FAD-linked mutations will be discussed.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 75 条
  • [1] Unusual phenotypic alteration of β amyloid precursor protein (βAPP) maturation by a new Val-715→Met βAPP-770 mutation responsible for probable early-onset Alzheimer's disease
    Ancolio, K
    Dumanchin, C
    Barelli, H
    Warter, JM
    Brice, A
    Campion, D
    Frébourg, T
    Checler, F
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (07) : 4119 - 4124
  • [2] alpha-secretase-derived product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease
    Ancolio, K
    Marambaud, P
    Dauch, P
    Checler, F
    [J]. JOURNAL OF NEUROCHEMISTRY, 1997, 69 (06) : 2494 - 2499
  • [3] Characterization of new polyclonal antibodies specific for 40 and 42 amino acid long amyloid beta peptides: Their use to examine the cell biology of presenilins and the immunohistochemistry of sporadic Alzheimer's disease and cerebral amyloid angiopathy cases
    Barelli, HL
    Lebeau, A
    Vizzavona, J
    Delaere, P
    Chevallier, N
    Drouot, C
    Marambaud, P
    Ancolio, K
    Buxbaum, JD
    Khorkova, O
    Heroux, J
    Sahasrabudhe, S
    Martinez, J
    Warter, JM
    Mohr, M
    Checler, F
    [J]. MOLECULAR MEDICINE, 1997, 3 (10) : 695 - 707
  • [4] Baumeister R, 1997, Genes Funct, V1, P149
  • [5] Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins
    Borchelt, DR
    Ratovitski, T
    vanLare, J
    Lee, MK
    Gonzales, V
    Jenkins, NA
    Copeland, NG
    Price, DL
    Sisodia, SS
    [J]. NEURON, 1997, 19 (04) : 939 - 945
  • [6] Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo
    Borchelt, DR
    Thinakaran, G
    Eckman, CB
    Lee, MK
    Davenport, F
    Ratovitsky, T
    Prada, CM
    Kim, G
    Seekins, S
    Yager, D
    Slunt, HH
    Wang, R
    Seeger, M
    Levey, AI
    Gandy, SE
    Copeland, NG
    Jenkins, NA
    Price, DL
    Younkin, SG
    [J]. NEURON, 1996, 17 (05) : 1005 - 1013
  • [7] BURDICK D, 1992, J BIOL CHEM, V267, P546
  • [8] Bursztajn S, 1998, J NEUROSCI, V18, P9790
  • [9] Calsenilin: A calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment
    Buxbaum, JD
    Choi, EK
    Luo, YX
    Lilliehook, C
    Crowley, AC
    Merriam, DE
    Wasco, W
    [J]. NATURE MEDICINE, 1998, 4 (10) : 1177 - 1181
  • [10] CHECLER F, 1995, J NEUROCHEM, V65, P1431